DoD Prostate Cancer Research Program anticipated funding opportunities for FY23

Xtandi + leuprolide improves OS in non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence, phase III data show

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the overall survival analysis from the phase III EMBARK study evaluating Xtandi (enzalutamide), an androgen receptor signaling inhibitor, in combination with leuprolide, and as a monotherapy in men with non-metastatic hormone-sensitive prostate cancer with biochemical recurrence at high risk for metastasis.

July 11, 2025

Vol.51 No.27

Podcast

In The Headlines: George Weiner on the importance of patients’ stories

In last week’s issue of The Cancer Letter, the cover story featured Col. Susan Fondy, an Army veteran and stage 3 breast cancer survivor, who is now living with lymphedema. Fondy is now a lymphedema advocate, working to prevent further cuts to the already-sparse funding for the disease.

July 09, 2025

Vol.51 No.26

Clinical

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

Don’t try to convince Col. Susan Fondy that lymphedema doesn’t merit interest from medical researchers.

July 03, 2025

Vol.51 No.26

By Jacquelyn Cobb

In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater

Source: NIH vigil organizerSince early May, a group of current and former NIH employees have gathered every Saturday at the Medical Center Metro station in Bethesda, MD, to mourn what they describe as the loss of scientific progress under the Trump administration.

July 03, 2025

Vol.51 No.26

By Claire Marie Porter

In the Archives

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

When the Women’s Health Initiative was announced in 1991, it was set to be the largest women’s health study ever conducted. The WHI scope is massive: the initiative has recruited more than 161,000 women and engaged more than 5,000 scientists from the U.S. and beyond.

July 03, 2025

Vol.51 No.26

Cancer Policy

Congress passes Trump’s megabill featuring historically steep Medicaid cuts

The U.S. House of Representatives Thursday passed President Trump’s “One Big Beautiful Bill,” a sweeping legislation that makes the biggest cuts to Medicaid since the program began in the 1960s.

July 03, 2025

Vol.51 No.26

By Claire Marie Porter

DoD Prostate Cancer Research Program anticipated funding opportunities for FY23

YOU MAY BE INTERESTED IN

Xtandi + leuprolide improves OS in non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence, phase III data show

In The Headlines: George Weiner on the importance of patients’ stories

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

Congress passes Trump’s megabill featuring historically steep Medicaid cuts

Renew today!

Subscriber content

Never miss an issue!

Login

DoD Prostate Cancer Research Program anticipated funding opportunities for FY23

YOU MAY BE INTERESTED IN

Xtandi + leuprolide improves OS in non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence, phase III data show

In The Headlines: George Weiner on the importance of patients’ stories

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

In weekly vigils, current and former NIH staff grieve the impact of Trump cutsThe Saturday gatherings at NIH’s Metro station are part graveside service, part street theater

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

Congress passes Trump’s megabill featuring historically steep Medicaid cuts

Never miss an issue!

Login

In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater